Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Eisai
Pharma
GSK-Hansoh, Merck-Kelun, AZ-Dizal—Fierce Pharma Asia
Kelun and Hansoh reported positive phase 3s for their Big Pharma-partnered ADCs. AZ buys an EGFR lung cancer med from its spinout Dizal. And more.
Angus Liu
Jul 17, 2026 9:38am
Drugmaker caught faking doctors’ petition to evade China price cut
Jul 8, 2026 11:31am
Eisai gets UK backing as it expands plant for Leqembi production
Jun 15, 2026 10:20am
Lilly, Biogen, Eisai and Genentech sponsor Alzheimer’s podcast
Jun 12, 2026 9:09am
Eisai whips up Alzheimer’s guidance to expand nutrition program
Jun 2, 2026 5:44am
Merck-Kelun, China deal wisdom, Takeda—Fierce Pharma Asia
May 22, 2026 8:53am
